Drugs Made in America Acquisition Corp. (DMAAU)
Market Closed
24 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 99
0
0%
$
359.76M Market Cap
- Div Yield
2 Volume
$ 10.99
Previous Close Investors:
Want to track DMAAU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made in America Acquisition Corp. (DMAAU) Statistics
Valuation metrics
Market Cap 359.76M
Enterprise value 360.86M
Trailing P/E (ttm) 52.3
Forward P/E -
PEG ratio -0.52
Price/Sales (ttm) -
Price/Book (mrq) 1.05
Enterprise Value/Revenue -
Enterprise Value/EBITDA -137.29
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 33
Average volume (90 days) 1.1K
Price summary
52-Week low 10.3
52-Week high 12.5
Beta -
50-Day moving average 11.12
200-Day moving average 10.6
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.03%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.29
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 0.03%
Book value per share (mrq) 10.2
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
